SCHEMBL240223

SCHEMBL240223

NS(=O)(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901447 0.72
SCHEMBL11608955 0.68
SCHEMBL907804 0.67
SCHEMBL1162544 0.67
SCHEMBL31189297 0.67
Ethanesulfonic Acid Amide SCHEMBL28038 0.67
SCHEMBL5115519 0.67
SCHEMBL300230 0.67
SCHEMBL1644673 0.67 CA2 (0.46)
SCHEMBL6200028 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084613-B2 Tetrazoyloxime derivative and plant disease control agent NIPPON SODA CO., LTD. (JP) 2011-12-27 US claimed
US-20220380370-A1 XANTHINE CB1 INHIBITORS GFB (ABC), LLC 2022-12-01 US disclosed
EP-4034101-A1 XANTHINE CB1 INHIBITORS Goldfinch Bio, Inc. (US) 2022-08-03 EP disclosed
CN-114727983-A Xanthine CB1 inhibitors 金翅雀生物公司 2022-07-08 CN disclosed
WO-2021083438-A1 INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE - SYNTHESIS AND USE THEREOF FOR TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) 2021-05-06 WO disclosed
WO-2021083438-A1 INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE - SYNTHESIS AND USE THEREOF FOR TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) 2021-05-06 WO disclosed
WO-2021062089-A1 XANTHINE CB1 INHIBITORS GOLDFINCH BIO, INC. (US) 2021-04-01 WO disclosed
US-10647725-B2 Anti-infective 2-aminothiophenes THE UNIVERSITY OF TOLEDO (US) 2020-05-12 US disclosed
CN-107205396-B Pesticide composition 日本曹达株式会社 2019-08-30 CN disclosed
US-20190119296-A1 Anti-Infective 2-Aminothiophenes THE UNIVERSITY OF TOLEDO (US) 2019-04-25 US disclosed
CN-1202168-A Quinolein-2(1H)-one derivatives as serotonin antagonists SYNTHELABO (FR) 1998-12-16 CN disclosed
WO-1998042712-A1 QUINOLINE-2(1H)-ONE AND DIHYDROQUINOLINE-2(1H)-ONE DERIVATIVES AS LIGANDS OF 5-HT, 5-HT2 AND 5-HT1-LIKE RECEPTORS SANOFI-SYNTHELABO (FR) 1998-10-01 WO disclosed
EP-0850235-A1 QUINOLEIN-2(1H)-ONE DERIVATIVES AS SEROTONIN ANTAGONISTS SYNTHELABO (FR) 1998-07-01 EP disclosed
WO-1997010238-A1 QUINOLEIN-2(1H)-ONE DERIVATIVES AS SEROTONIN ANTAGONISTS SYNTHELABO (FR) 1997-03-20 WO disclosed
EP-0252640-B1 ALKANESULFONAMIDES AS ANTIGLAUCOMA AGENTS MERCK & CO. INC. (US) 1991-03-06 EP disclosed
US-4968809-A Spirofluoreneisothiazolidinone dioxides as aldose reductase inhibitors NESTLE S.A. A COMPANY OF SWITZERLAND (CH) 1990-11-06 US disclosed
US-4812463-A CARBONIC ANHYDRASE INHIBITORS MERCK & CO., INC. (US) 1989-03-14 US disclosed
EP-0252640-A1 Alkanesulfonamides as antiglaucoma agents MERCK & CO. INC. (US) 1988-01-13 EP disclosed
EP-0129478-A2 2-Sulfamoylbenzo (b) thiophene derivatives, their preparation and pharmaceutical composition for the treatment of elevated intraocular pressure MERCK & CO. INC. (US) 1984-12-27 EP disclosed
US-4068000-A N-TETRACHLOROETHYL-THIO-SUBSTITUTED HALOMETHANESULFONAMIDES, OVICIDES CHEVRON RESEARCH COMPANY (US) 1978-01-10 US disclosed